BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9
27 results:

  • 1. Genotype Distribution and Prevalence of High-Risk Human Papillomavirus Infection among Women in Samsun Province of Turkey.
    Taskin MH; Nursal AF; Oruc MA; Kariptas E
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2477-2482. PubMed ID: 35901356
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetic polymorphisms in DNA repair genes and their association with risk of cervical cancer: A systematic review and meta-analysis.
    Shao X; Yang X; Liu Y; Song Q; Pan X; Chen W; Jiang W; Xu D; Song Y; Chen R
    J Obstet Gynaecol Res; 2022 Sep; 48(9):2405-2418. PubMed ID: 35732591
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of cervical cancer: A Case-Control Study.
    Datkhile KD; Durgawale PP; Patil MN; Gudur RA; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2022 Apr; 23(4):1291-1300. PubMed ID: 35485688
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IQGAP3, a YAP Target, Is Required for Proper Cell-Cycle Progression and Genome Stability.
    Leone M; Cazorla-Vázquez S; Ferrazzi F; Wiederstein JL; Gründl M; Weinstock G; Vergarajauregui S; Eckstein M; Krüger M; Gaubatz S; Engel FB
    Mol Cancer Res; 2021 Oct; 19(10):1712-1726. PubMed ID: 34183451
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.
    Alholm Z; Monk BJ; Ting J; Pulgar S; Boyd M; Sudharshan L; Bains S; Nicacio L; Coleman RL
    Gynecol Oncol; 2021 May; 161(2):422-428. PubMed ID: 33741208
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center.
    Boustani J; Achkar S; Bertaut A; Genestie C; Gouy S; Pautier P; Morice P; Haie-Meder C; Chargari C
    Cancer Radiother; 2021 May; 25(3):207-212. PubMed ID: 33408051
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
    Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
    J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women.
    Ermel A; Tonui P; Titus M; Tong Y; Wong N; Ong'echa J; Muthoka K; Kiptoo S; Moormann A; Hogan J; Mwangi A; Cu-Uvin S; Loehrer PJ; Orang'o O; Brown D
    BMC Infect Dis; 2019 Apr; 19(1):352. PubMed ID: 31029097
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.
    Borchiellini D; Etienne-Grimaldi MC; Bensadoun RJ; Benezery K; Dassonville O; Poissonnet G; Llorca L; Ebran N; Formento P; Château Y; Thariat J; Milano G
    Oral Oncol; 2017 Apr; 67():70-76. PubMed ID: 28351583
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Time to clinical investigation for Indigenous and non-Indigenous Queensland women after a high grade abnormal Pap smear, 2000-2009.
    Whop LJ; Baade PD; Brotherton JM; Canfell K; Cunningham J; Gertig D; Lokuge K; Garvey G; Moore SP; Diaz A; O'Connell DL; Valery P; Roder DM; Condon JR
    Med J Aust; 2017 Feb; 206(2):73-77. PubMed ID: 28152354
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epidemiological Investigation and Risk Factors for cervical Lesions: cervical cancer Screening Among Women in Rural Areas of Henan Province China.
    Zhang Q; Xie W; Wang F; Li RH; Cui L; Wang H; Fu X; Song J
    Med Sci Monit; 2016 Jun; 22():1858-65. PubMed ID: 27249229
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nucleotide Excision Repair Gene ercc2 and ERCC5 Variants Increase Risk of Uterine cervical cancer.
    Joo J; Yoon KA; Hayashi T; Kong SY; Shin HJ; Park B; Kim YM; Hwang SH; Kim J; Shin A; Kim JY
    Cancer Res Treat; 2016 Apr; 48(2):708-14. PubMed ID: 26130668
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Influence of Morinda citrifolia (Noni) on Expression of DNA Repair Genes in cervical cancer Cells.
    Gupta RK; Bajpai D; Singh N
    Asian Pac J Cancer Prev; 2015; 16(8):3457-61. PubMed ID: 25921162
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in the DNA repair genes in HPV-positive cervical cancer.
    Bajpai D; Banerjee A; Pathak S; Thakur B; Jain SK; Singh N
    Eur J Cancer Prev; 2016 May; 25(3):224-31. PubMed ID: 25812040
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The prediction of candidate genes for cervix related cancer through gene ontology and graph theoretical approach.
    Hindumathi V; Kranthi T; Rao SB; Manimaran P
    Mol Biosyst; 2014 Jun; 10(6):1450-60. PubMed ID: 24647578
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Decreased expression of DNA repair genes (XRCC1, ERCC1, ercc2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix.
    Bajpai D; Banerjee A; Pathak S; Jain SK; Singh N
    Mol Cell Biochem; 2013 May; 377(1-2):45-53. PubMed ID: 23435956
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Nucleotide excision repair gene subunit xpd is highly expressed in cervical squamous cell carcinoma.
    Ye F; Jiao J; Zhou C; Cheng Q; Chen H
    Pathol Oncol Res; 2012 Oct; 18(4):969-75. PubMed ID: 22760492
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey.
    Tiro JA; Tsui J; Bauer HM; Yamada E; Kobrin S; Breen N
    J Womens Health (Larchmt); 2012 Jun; 21(6):656-65. PubMed ID: 22420920
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A novel functional site of extracellular matrix metalloproteinase inducer (EMMPRIN) that limits the migration of human uterine cervical carcinoma cells.
    Sato T; Watanabe M; Hashimoto K; Ota T; Akimoto N; Imada K; Nomizu M; Ito A
    Int J Oncol; 2012 Jan; 40(1):236-42. PubMed ID: 21994090
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of pathways involved in paclitaxel activity in cervical cancer.
    Qiao WJ; Cheng HY; Li CQ; Jin H; Yang SS; Li X; Zhang YY
    Asian Pac J Cancer Prev; 2011; 12(1):99-102. PubMed ID: 21517239
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.